Reduce or cover visible redness without claiming to treat rosacea

Choose cosmetic color correction or comfort-focused care while keeping inflammatory conditions outside the recommendation.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Neutralize redness gently and refer persistent inflammation

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

Green-toned coverage can look gray if the shade and amount are wrong.
Persistent redness or inflammation should not be managed only through cosmetic claims.

WHAT WE ARE NOT CLAIMING

The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Neutralize redness gently and refer persistent inflammation

A reasoned course of action; not a product result measured by the source.

BOUNDARY OF THE CALL

Green-toned coverage can look gray if the shade and amount are wrong.

The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

Primary and professional sources in the record

Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
Cosmetics Labeling ClaimsU.S. Food and Drug Administration
Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
21 CFR Part 740 — Cosmetic Product Warning StatementsOffice of the Federal Register / eCFR
FDA Adverse Event Monitoring System (AEMS)U.S. Food and Drug Administration